Therapeutic effects of nano-HAp in a rat model of AlCl3 induced neurotoxicity

Document Type : Research article

Authors

Radioisotopes Department, Egyptian Atomic Energy Authority, Cairo, Egypt.

Abstract

With the advance in nanomedicine, the present study was conducted to explore the possible therapeutic role of intravenous nano- hydroxyapatite (nano-HAp) into male rats after chronic exposure to aluminum chloride (AlCl3). This exposure interposed DNA fragmentation, apoptosis, alters oxidant/antioxidant status as well as change in content of neurotransmitters. The rats were injected with 100 mg/kg. body weight (b.w.) of AlCl3 intraperitoneally for 90 days, after then nano-HAp was injected intravenously (i.v.) three times per week at a dose level 100 mg/kg b.w.Based on the results obtained, it can be concluded that the treatment with the prepared nano-HAp restrains the damage inflicted on brain modulating by lipid oxidation products and decreased the susceptibility of apoptotic cells death with subsequent repaired the fragmented DNA as well as improved the synthesis of neurotransmitters. The most salient findings for nano-HAp treatment are that most of the pathological changes due to AlCl3 administration were disappeared.

Keywords

Main Subjects


Stevanović I, Jovanović M, Jelenković A, Čolić M and
Ninković M. Effects of various nitric oxide synthase

inhibitors on AlCl3-induced neuronal injury in rats.
J.
Serb. Chem. Soc
. (2009) 74: 503–11.
(1)
 
Therapeutic Effects of Nano-HAp on neurotoxicity1321
Sumathi T, Shobana C, Mahalakshmi V, Sureka R,

Subathra M, Vishali A and Rekha K. Oxidative Stress

In Brains Of Male Rats Intoxicated With Aluminium

And Neuromodulating Effect Of Celastrus Paniculatus

Alcoholic Seed Extract.
Asian. J. Pharm. Clin. Res .
(2013) 6: 80-90.

Moshtaghie AA,Malekpouri P, Moshtaghie M,

Mohammadi-nejad M and Ani M. Protective

effects of copper against aluminum toxicity on

acetylcholinesterase and catecholamine contents of

different regions of rat’s brain.
Neurol. Sci. (2013) 34:
1639–1650.

Kobayashi K. Role of catecholamine signaling in

brain and nervous system functions: new insights from

mouse molecular genetic study.
J. Invest. Dermatol.
Symp. Proc.
(2001) 6:115–121.
Aoki H, Akao M, Shin Y, Tsuzi T and Togawa T.

Sintered hydroxyapatite for a percutaneous device and

its clinical application.
Med. Prog. Technol. (1987)
12: 213-20.

Grote JJ. Reconstruction of the ossicular chain with

hydroxyapatite prostheses.
Am. J. Otol. (1987) 8:
396-401.

Hu J, Liu ZS, Tang SL and He YM. Effect of

hydroxyapatite nanoparticles on the growth and

p53/c-Myc protein expression of implanted hepatic

VX2 tumor in rabbits by intravenous injection.

Gastroenterology
(2007) 13: 2798-802.
Bauer IW, Li SP, Han YC and Yin LM. Internalization

of hydroxyapatite nanoparticles in liver cancer cells.
J.
Mater. Sci. Mater. Med.
(2008) 19: 1091 5.
Suchanek W and Yoshimura M. Processing and

properties of hydroxyapatite-based biomaterials for

use as hard tissue replacement implants.
J. Mater. Res.
(1998) 3: 94-117.

Nakano T, Tokumura A and Umakoshi Y. Variation in

Crystallinity of hydroxyapatite and the related calcium

phosphates by mechanical grinding and subsequent

heat treatment.
Metall. Mater. Trans. A. (2002) 33:
521-8.

Abdel-gawad EI and Awwad SA.
In-vivo and in-vitro
Prediction of the Efficiency of Nano-Synthesized

Material in Removal of Lead Nitrate Toxicity.
J. Am.
Sci.
(2011) 7: 105-19.
El Agamy BEA. Potential Impact of a Synthesized

Nanocomposite Material in Treatment of Different

Forms of Liver Injury in Rats. Thesis Submitted

for the Award of Ph. D in Biochemistry. Ain Shams

University Faculty of Science Department of

Biochemistry. (2014).

Xu Z, Sun J, Liu C and Wei J. Effect of hydroxyapatite

nanoparticles of different concentrations on rat

osteoblast.
Materials Science Forum. (2009) 610-613:
1364-9.

Hussain NS, Gomes PS, Fernandes MH, Lopes MA

and Santos JD. Assessment of the osteoblastic cell

response to a zinc glass reinforced hydroxyapatite

composite (Zn-GRHA). International.
J. Nano.
Biomaterials.
(2009) 2: 100-9.
(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

(10)

(11)

(12)

(13)

(14)

Abdel-Gawad EI and Awwad SA. Biocompatibility of

Intravenous Nano Hydroxyapatite in Male Rats.
Nat.
Sci
. (2010) 8: 60-8.
Abdelfattah W, Fayed M, Gouda Sh and Awwad

S. Nano Hydroxyapatite gel for removal of nickel

ions for environmental applications.
Isotope Rad. Res.
(2006) 38: 417–27.

Lorke D. A new approach to tropical acute toxicity

testing.
Arch. Toxico. (1983) 53: 275-87.
Xie JSG. Tissue distribution of intravenously

administrated hydroxyapatite nanoparticles labeled

with 125I. Nanoelectronics Conference (INEC), 3rd

International, Hong Kong, China (2010) 1415–6.

Singh NP, McCoy MT, Tice RR and Schneider EL.

A simple technique for quantitation of low levels of

DNA damage in individual cells.
Exp. Cell Res. (1988)
175: 184-91.

Zagrodzka J, Romaniuk A, Wieczorek M and

Boguszewski P. Bicuculline administration into

ventromedial hypothalamus: effects on fear and

regional brain monoamines and GABA concentrations

in rats.
Acta Neurobiol. Exp. (Wars). (2000) 60: 333-
43.

Banchroft JD, Stevens A and Turner DR. Theory

and practice of histological techniques. Fourth Ed.

Churchil Livingstone, New york, London, San

Francisco, Tokyo (1996).

Fu Q, Hong Y, Liu X, Fan H and Zhang X. A

hierarchically graded bioactive scaffold bonded

to titanium substrates for attachment to bone.

Biomaterials
(2011) 32: 7333–46.
Hou CJ, Liu JL, Li X and Bi LJ. Insulin promotes bone

formation in augmented maxillary sinus in diabetic

rabbits.
Int. J. Oral. Maxillofac. Surg. (2012) 41:
400–7.

Ozawa M and Kanahara S. Removal of aqueous lead

by fish-bone waste hydroxyapatite powder.
J. Mat. Sci.
(2005) 40: 1037–8.

Stötzel C, Müller FA, Reinert F, Niederdraenk F,

Barralet J and Gbureck U. Ion adsorption behaviour of

hydroxyapatite with different crystallinities.
Colloids
Surf. Bionterfaces
(2009) 74: 91-5.
Chu SH, Karri S, Ma YB, Feng, DF and Li ZQ.

In- vitro
and in-vivo radiosensitization induced by
hydroxyapatite nanoparticles.
Neuro. Oncol. (2013)
15: 880–90.

Boeck MDe, Touil N, Visscher GDe, Vande PA and

Kirsch-Volders M. Validation and implementation of

an internal standard in comet assay analysis.
Mutat.
Res.
(2000) 469: 181-97.
Halliwell B. Role of free radicals in the

neurodegenerative diseases: therapeutic implications

for antioxidant treatment.
Drugs Aging (2001) 18:
685-716.

Dong X, Wang Y and Qin Z. Molecular mechanisms

of excitotoxicity and their relevance to pathogenesis

of neurodegenerative diseases.
Acta Pharmacol. Sin.
(2009) 30: 379–87.

Ahmeda HH, Zaazaab AM and Abd El-Motelpb

(15)

(16)

(17)

(18)

(19)

(20)

(21)

(22)

(23)

(24)

(25)

(26)

(27)

(28)

(29)

(30)
 
Abbas OA et al. / IJPR (2019), 18 (3): 1309-13221322
BA. Zingiber officinale and Alzheimer’s Disease:

Evidences and Mechanisms.
Int. J. Pharm. Sci. Rev.
Res.
(2014) 27: 142-52.
Biswas M and Chan JY, “Role of Nrf1 in antioxidant

response element-mediated gene expression and

beyond.
Toxicol. Appl. Pharmacol. (2010) 244: 16–20.
Tsuchiya Y, Morita T, Kim M, Iemura S, Natsume T,

Yamamoto M and Kobayashi A. Dual regulation of the

transcriptional activity of Nrf1 by β-TrCP- and Hrd1

dependent degradation mechanisms.
Mol. Cell Biol.
(2011) 31: 4500-12.

Abdel-Salam OM, El-Shamarka ME and Omara E.

A. Modulation of Neurobehavioral and Biochemical

Alterations Induced by Aluminum Chloride with

Cannabis sativa Extract.
Cell. Biol. Res. Ther. (2015)
4:
1 .
Prakash A and Kumar A. Effect of N-acetyl cysteine

against aluminium-induced cognitive dysfunction and

oxidative damage in rats.
Basic. Clin. Pharmacol.
Toxicol.
(2009) 105: 98-104.
Singh S, Singh R, Kushwah AS and Gupta

G. Neuroprotective role of antioxidant and

pyranocarboxylic acid derivative against AlCl
3
induced Alzheimer’s disease in rats.
J. Coast. Life
Med.
(2014) 2: 571-8.
Amjad S and Umesalma S. Protective Effect of Centella

asiatica against Aluminium-Induced Neurotoxicity

in Cerebral Cortex, Striatum, Hypothalamus and

Hippocampus of Rat Brain-Histopathological, and

Biochemical Approach.
J. Mol. Biomark. Diagn.
(2015) 6: 212.

Mohamd EM, Ahmed HH, Estefan SF, Farrag AE and

Salah RS. Windows into estradiol effects inAlzheimer’s

disease therapy.
Eur. Rev. Med. Pharmacol. Sci(2011) .
1131-40
:15.
Kumar V and Gill K. D. Aluminium neurotoxicity:

neurobehavioural and oxidative aspects.
Arch. Toxicol.
(2009) 83: 965-78.

Thirunavukkarasu SV, Jayanthi M, Raja S and

Venkataraman S. Effect of Manasamitra Vatakam

Against Aluminium Induced Learning and Memory

Impairment of Apoptosis in Rat’s Hippocampus and

Cortex.
J. Drug Metab. Toxicol. (2013) 4: 154.
Milhas D, Clarke CJ, Idkowiak-Baldys J, Canals D

and Hannun YA. Anterograde and retrograde transport

(31)

(32)

(33)

(34)

(35)

(36)

(37)

(38)

(39)

(40)

of neutral sphingomyelinase-2 between the Golgi and

the plasma membrane.
Biochim. Biophys. Acta (2010)
1801: 1361–74.

Pandya JD, Dave KR and Katyare SS. Effect of long-

term aluminum feeding on lipid/phospholipid profiles

of rat brain myelin.
Lipids Health Dis. (2004) 3: 13.
Musacchio JM. Chapter 1: Enzymes involved in the

biosynthesis and degradation of catecholamines. In

Iverson L. Biochemistry of Biogenic Amines. Springer.

(2013): 1–35.

Flaten TP. Aluminium as a risk factor in Alzheimer’s

disease, with emphasis on drinking water.
Brain Res.
Bull.
(2001) 55: 187–96.
Moshtaghie AA, Rahimi S and Messripour M. Changes

in catecholamine levels of cerebellum, mid-brain and

brain-cortex in aluminium intoxified rats.
Indian J.
Pharmacol.
(1996) 28: 244–8.
Scherbart CA, Agnes M, van Berlo D, Braunbarth CM,

Schins RP and Scheel J. Evaluation of cytotoxic effects

and oxidative stress with hydroxyapatite dispersions of

different physicochemical properties in rat NR8383

cells and primary macrophage.
Toxicology in Vitro.
(2009) 23: 520–30.

Fouda MFA, Nemat A, Gawish A, Ayman R and

Baiuomy AR. Does the Coating of Titanium Implants

by Hydroxyapatite affect the Elaboration of Free

Radicals? An Experimental Study.
Aust. J. Basic Appl.
Sci.
(2009) 3: 1122-9.
Jain KK. Nanobiotechnology-Based Strategies for

Crossing the Blood–Brain Barrier
Nanomedicine
(2012) 7: 1225-33.

Lin W, Chen R, Lu W, Liu S and Yang F. Protective

effects of low-intensity pulsed ultrasound on

aluminum-induced cerebral damage in Alzheimer’s

disease rat model.
Sci. Rep. (2015) 5: 9671.
Sharon M. Should Nano-particles Be Used to

Cross Blood Brain Barrier to Deliver Drugs to

Neurodegenerative Disease?
Nov. Appro. Drug Des.
Dev.
(2017) 1: 1-3.
Bihaqi SW, Sharma M, Singh AP and Tiwari M.

Neuroprotective role of Convolvulus pluricaulis on

aluminium induced neurotoxicity in rat brain.
J.
Ethnopharmacol.
(2009) 124: 409-15.